Cbfa1, a developmentally expressed transcription factor of the runt family, was recently shown to be essential for osteoblast differentiation. We have investigated the role of Cbfa1 in endochondral bone formation using Cbfa1-deficient mice. Histology and in situ hybridization with probes for Indian hedgehog (Ihh), collagen type X and osteopontin performed at E13.5, E14.5 and E17.5 demonstrated a lack of hypertrophic chondrocytes in the anlagen of the humerus and the phalanges and a delayed onset of hypertrophy in radius/ulna in Cbfa1
Introduction
The development of a skeleton is a complex, multi-step process involving two different types of bone formation, desmal and endochondral. In areas of desmal ossification (skull, mandible) bone is formed directly by the differentiation of precursor cells into osteoblasts. In contrast, in areas of endochondral ossification (all long bones, vertebrae) a cartilage template is formed first (anlage) that is subsequently transformed into bone. During the initial phase of this process, mesenchymal stem cells condense and differentiate into chondrocytes forming a cartilaginous model of the future bone. Chondrocytes within this cartilage model initially undergo rapid proliferation producing a large amount of extracellular matrix, then cease proliferation to become hypertrophic. Once fated to hypertrophy, chondrocytes greatly increase their intracellular volume, they start expressing stage specific matrix components such as collagen type X and the matrix subsequently calcifies. As mineralization proceeds, the tissue is invaded by blood vessels, and the cartilage is removed and replaced by bone. Endochondral bone formation takes place in the growth plate, a highly specialized organ that generates practically all longitudinal growth until adulthood has been reached (for review see Erlebacher et al., 1995) .
The intricate control of chondrocyte differentiation within the growth plate is essential for normal growth. Any significant disturbance of this process leads to disproportionate dwarfism as exemplified by the large number of syndromes resulting from abnormal growth plate function (for review see Mundlos and Olsen, 1997a,b) . The mechanisms of molecular control of chondrocyte differentiation are slowly emerging. A feedback loop between Indian hedgehog (Ihh) and Parathyroid hormone related peptide (PTHrP) and its receptor has recently been shown to regulate, at least in part, the transition from proliferation to hypertrophy Vortkamp et al., 1996) . Other factors such as the BMPs are likely to be involved (Zou et al., 1998) .
Cbfa1 belongs to a family of transcription factors with strong homology to the Drosophila pair-rule gene runt. The gene was recently shown to be essential for osteoblast differentiation and skeletal patterning (Ducy et al., 1997; Komori et al., 1997; Otto et al., 1997) . Mice that are homozygous for a targeted mutation of the Cbfa1 gene completely lack differentiated osteoblasts and are thus devoid of bone. Mice that are heterozygous for the mutation are viable and show a number of skeletal changes that are phenotypically similar to those observed in a human skeletal condition named cleidocranial dysplasia (CCD) (Mundlos et al., 1996) . Characteristic changes of this dominantly inherited condition include delayed closure of fontanelles, hypoplastic/aplastic clavicles, and short stature. As in the mouse, the phenotype is caused by heterozygous deletions of the CBFA1 locus, or by mutations that presumably lead to an inactivation of the CBFA1 protein (Mundlos et al., 1997c) . In a previous study we were able to demonstrate a role for Cbfa1 in the differentiation of clavicular precursor cells into chondrocytes and osteoblasts (Huang et al., 1997) . The combination of symptoms observed in CCD make it likely that the mutated gene is not only active during desmal ossification but also directly or indirectly involved in the process of endochondral ossification.
In this study we have investigated the role of Cbfa1 during cartilage differentiation. The different stages of chondrocyte differentiation and the expression of several marker genes were investigated in Cbfa1 deficient mice of various developmental stages. In addition, we performed a detailed analysis of Cbfa1 expression during skeletal development. The results demonstrate that the expression of Cbfa1 is not specific to osteoblasts. Rather, Cbfa1 is expressed in areas of direct bone formation as well as in chondrocytes of endochondral bone formation. Mice with deficient Cbfa1 alleles show severely diminished hypertrophy indicating that Cbfa1 is responsible not only for osteoblast differentiation, but also for the regulation of chondrocyte hypertrophy.
Results

Expression of Cbfa1
The expression of Cbfa1 was analyzed by whole mount in situ hybridization and by lacZ staining of embryos, newborn, and adult mice. Results of whole mount in situ hybridizations at stages E11.5, E12.5 and E13.5 performed in Cbfa1 +/+ embryos were identical in distribution and intensity to the results obtained in Cbfa1 +/− embryos with lacZ staining. In all subsequent studies only lacZ staining was used. Fig. 1 demonstrates staining in limbs of stages E12.5, E13.5, and E14.5. Strong expression was observed at E11.5 in the primordia of the jaw, the presumptive shoulder girdle region, and, to a lesser degree, in the condensation of the humerus (not shown). At E12.5 strong staining was present in the anlagen of the humerus/femur, radius and ulna/tibia and fibula, the ribs, and the developing facial bones. At E13.5 expression appeared in the vertebral bodies, in the primordia of the claws, and, depending on the individual developmental stage, in some of the proximal phalanges of the upper limb. Expression in non-skeletal tissues was not observed at any of the time points investigated.
To analyze the cellular distribution within the anlagen and the growth plate, limbs of lacZ stained embryos were plastic embedded, sectioned and analyzed with dark field microscopy as described (Lazik et al., 1996) . In dark field illumination cells containing the X-Gal product stained bright pink contrasted against a dark background of unstained tissue. Sharp resolution on a cellular level and easy visualization of the exclusively intracytoplasmatic signal made the differentiation between lacZ+ and lacZ− cells unambiguous and ruled out significant diffusion of X-Gal into non-expressing cells. The pattern of Cbfa1 expression during different stages of limb development is shown in Fig. 2 . Expression within the three fore limb segments (humerus, radius/ulna, and phalanges/metacarpals) was similar and followed the same scheme. At E12.5 expression was found in the anlagen of humerus and radius/ulna primarily in cells of the perichondrium and, to a lesser degree, in chondrocytes. Based on morphology and the lack of Col-X expression, chondrocytes were pre-hypertrophic at this stage. Similar observations were made at E14.5 in the phalanges where condensation is still actively occurring. Expression of Cbfa1 seems to start in the perichondrium around the central regions of the anlage and, subsequently, appears in pre-hypertrophic and then hypertrophic chondrocytes ( Fig. 2A ,B,E,F). Thus, expression of Cbfa1 precedes hypertrophy. Expression in the perichondrium was diffuse in the early stages (ϽE13.5) and restricted to the cells directly adjacent to the cartilage in the later stages (E17.5). The domain of perichondrial expression included the area of Cbfa1 expression in cartilage (hypertrophic and pre-hypertrophic) and covered the proliferative and part of the resting zone. Along with the formation of bone (E14.5) strong expression was observed in osteoblasts. Sections of growth plates at E17.5 demonstrated expression in a pattern compatible with the findings of earlier stages (Fig. 2G,H) , i.e. expression in perichondrium, bone, and in chondrocytes of the hypertrophic zone and the transition zone. Expression of Cbfa1 in chondrocytes was similar to but not identical with the domain of Col-X expression (Mundlos, 1994). Expression was not confined to the upper hypertrophic zone, as observed for Col-X but was also present in calcified chondrocytes of the lower hypertrophic zone (region of osteopontin expression). In addition, expression extended beyond the hypertrophic zone (as defined by Col-X expression) into the transition zone (as defined by Ihh expression) (Fig. 3) . There was patchy expression in the proliferative zone and no expression in the resting zone.
Postnatally, expression of Cbfa1 diminishes and mature bone is practically devoid of staining (not shown). No expression was found in other organs or cells. Expression in calvarial bones is confined to the suture area, the area of new bone formation (not shown).
Histology and staining of developing bones
Histology was performed using H & E staining and van Kossa staining at developmental stages E12.5 to adulthood in wt, Cbfa1
, and Cbfa1 −/− mice (Fig. 4) . Histology of cartilage anlagen and growth plates revealed no significant difference between wt and Cbfa1 +/− mice (not shown). In contrast, Cbfa1 −/− mice showed a severe disturbance of growth plate architecture. The formation of the initial cartilaginous anlage was normal in all skeletal segments. However, further differentiation of chondrocytes and subsequent hypertrophy was absent in humerus and severely delayed in radius/ulna. In Cbfa1 −/− mice chondrocyte morphology of humeri and phalanges at E17.5 was similar to that of wt mice at E13 (pre-hypertrophic) (Fig. 4C ). In radius/ulna some hypertrophic cells became apparent by day 14.5 to 15.5 and calcified cartilage was observed at day 17.5 ( Fig.  4G ,H). Thus, the differentiation of chondrocytes in the zeugopod was delayed, but comparable to wt mice, whereas the stylopod showed no differentiation beyond the early anlage stage. Calcification of cartilage, as judged by alizarin red and van Kossa staining was absent or severely delayed in Cbfa1 −/− mice. At E17.5 no ossification was observed with the exception of radius/ulna and tibia/fibula. Here, calcification did not appear before E16.5, whereas wt mice showed calcification as early as E14.5. No vascular invasion was observed in areas of calcified cartilage.
Expression of Col-X and osteopontin
Col-X expression was used as a marker for hypertrophy. mice at E14.5. Expression in the phalanges was comparable to wt expression in intensity and timing (Fig. 5G,J) . In the anlagen of radius/ulna expression was weak and confined to a few cells in the center of the anlage (Fig. 5E,F) . By E17.5 the area of Col-X expression in radius/ulna was larger and similar to that of wt mice whereas expression in the phalanges was no longer demonstrable.
Osteopontin was used as a marker for terminally differentiated chondrocytes and osteoblasts (Fig. 7) . In wt mice, expression of osteopontin was first observed at E14.5 in humerus and radius/ulna along with the first ossification of cartilage. In this and later stages expression was confined to osteoblasts and hypertrophic cells of the calcified cartilage that do not express Col-X nor Col-II. In Cbfa1 −/− mice osteopontin was not expressed until E17.5. At this time point positive staining was observed in hypertrophic calcified cells in radius/ulna, but not in humerus or phalanges. hematoxilin is shown in (A), the arrow marks the bone-cartilage border. b, bone and bone marrow; hc, hypertrophic chondrocytes; p, proliferating chondrocytes; pc, perichondrium. The three genes are expressed in overlapping domains, with Ihh located distally followed by Col-X. The Cbfa1 expression domain appears to overlap both, Ihh and Col-X. Magnification: ×200. 
Expression of Indian hedgehog
Ihh plays a major role in the regulation of chondrocyte hypertrophy. The gene is expressed in an overlapping domain with Col-X in cells of the transition zone. No expression was detected in the humerus. In contrast, normal expression was found at E14.5 in the phalanges and, to a lesser degree, in radius/ulna. With further development expression was lost in the anlagen of the autopod but was still demonstrable in the stylopod.
The results for the expression of Ihh, Col-X, and osteopontin within the individual segments of the fore limb are summarized in Table 1 .
Expression of matrix genes
The expression pattern of several matrix genes was investigated in wt, Cbfa1
, and Cbfa1 −/− mice (Fig. 7) . Collagen type II (Col-II) served as a cartilage specific probe, whereas collagen type I (Col-I) was used as a perichondrium/bone specific probe. Osteonectin is expressed mainly in perichondrium and bone, but also in cartilage. In wt, Cbfa1
, and Cbfa1 −/− mice Col-II was strongly expressed throughout the developmental stages investigated, indicating that chondrocytes were healthy and metabolically active. The expression of Col-I and osteonectin (not shown) differed between Cbfa1 −/− and wt mice, but not between wt and heterozygous mice. In wt mice Col-I and osteonectin were expressed strongly in the perichondrium and newly formed bone/ osteoblasts. Cbfa1 −/− mice showed expression in perichondrial cells only. During the early stages of development (ϽE14.5) the intensity of the signal was comparable to controls, whereas by E17.5 the expression was significantly weaker, when compared to controls (Fig. 7G,H) .
Discussion
Our results provide evidence for a role of Cbfa1 in chondrocyte differentiation. Expression studies using whole mount and lacZ staining under the Cbfa1 promotor revealed strong expression of Cbfa1 not only in osteoblasts and in the perichondrium but also in pre-hypertrophic and hypertrophic chondrocytes. Mice with deficient Cbfa1 alleles completely lack hypertrophic chondrocytes (humerus) or show delayed and greatly diminished hypertrophy (radius/ ulna) as indicated by conventional staining techniques and stage specific gene expression. The results suggest that Cbfa1 is not only essential for osteoblast differentiation and bone formation, as implicated by earlier studies (Ducy et al., 1997; Komori et al., 1997; Otto et al. 1997 ), but also an important factor in the regulation of chondrocyte differentiation.
Conventional histology performed at developmental stages E13.5, E14.5 and E17.5 indicated a lack of hypertrophy and ossification in Cbfa1 −/− mice. Using in situ hybridization with stage specific probes we were able to confirm these observations. Col-X was used as a marker for hypertrophic chondrocytes, whereas osteopontin served as a marker for calcified hypertrophic chondrocytes and osteoblasts (Mundlos, 1994) . Our results provide evidence for a different degree of responsiveness to Cbfa1 within the three forelimb segments. Whereas the distal anlagen of the phalanges showed a timely expression of Col-X, the expression in the anlagen of radius/ulna was significantly delayed, and no expression was demonstrable in the humeri of Cbfa1 −/− mice. Mineralization of cartilage, as indicated by the expression of osteopontin and van Kossa staining, was similarly affected. Thus, the absence of Cbfa1 leads to an arrest in chondrocyte differentiation with the proximal limb segments being most severely affected. The different effects observed within the individual segments suggest that other genes besides Cbfa1 are involved in this process. Different segments of the skeleton grow at different rates to allow proportionate growth. The growth rate of individual segments is likely to be controlled by a number of genes regulating the pace of chondrocyte differentiation. Such genes may act from the perichondrium, or within the proliferating and differentiating chondrocytes. We have analyzed Cbfa1 expression in Cbfa1 +/− mice using a lacZ reporter gene, a standard experimental methodology for investigating gene regulation in vivo. An extensive comparison of bone development in wt and heterozygous mice using histological as well as in situ hybridization methods showed no significant difference in growth plate morphology or expression patterns, suggesting that Cbfa1 +/− mice can be used as an experimental model to study Cbfa1 expression. In addition, our results in heterozygous mice were confirmed by whole mount in situ hybridization experiments in wt mice. Distribution of Cbfa1 expression on a cellular level was investigated using plastic embedding and dark field microscopy. Plastic embedding was chosen over paraffin embedding or frozen sections since this technique allows detailed histological analysis with minimal tissue distortion and maximal sensitivity. Unlike paraffin, plastic embedding does not require organic solvents, which may leach out the lacZ product. The technique allows identification of the X-Gal product on a subcellular basis with high sensitivity and sharp resolution. In this study Cbfa1 was shown to be expressed in the perichondrium, as well as in chondrocytes. Within the cartilaginous anlage Cbfa1 expression was observed predominantly in hypertrophic chondrocytes overlapping with the pattern of Col-X and osteopontin expression. Comparison of (I,J), in radius of stages E14.5 (E,F), and E17.5 (K,L), and phalanges of stages E14 (G,J), and E17.5 (M,N). Note lack of Col-X expression in humeri of all stages, but expression in phalanges at E14.5 and in radius/ulna at E14.5 and E17.5. Expression is not maintained in phalanges and can no longer be detected at E17.5. hum, humerus; rad, radius; pha, phalanges. Magnification: ×200 (A,B,E,FG,H,I,K,L,M,N); ×100 (C,D,J). relative expression patterns in growth plates (Fig. 3 ) and early cartilaginous anlagen (Fig. 2 ) revealed an overlap with the Ihh expression domain. Our results are in contrast to previous studies where expression of Cbfa1 was detected in the early cartilaginous anlagen, but not in differentiated chondrocytes (Ducy et al., 1997) . Komori and coworkers did not find any significant expression in chondrocytes (Komori et al., 1997) . Ducy et al. (1997) report expression of Cbfa1 12-24 h before mineralization. Since cartilage mineralizes before bone, this activity most likely represents expression of Cbfa1 in hypertrophic and pre-hypertrophic chondrocytes and is thus consistent with our results. In addition, the authors report lack of Cbfa1 expression in Meckel's cartilage (a transient, specialized cartilage of the developing jaw). Again, this is in agreement with our concept since Meckel's cartilage never develops towards hypertrophy (as indicated by expression of collagen type X) and thus probably follows a different pathway of differentiation (Chung et al., 1995) . In contrast to other known factors of chondrocyte differentiation such as Ihh, bone morphogenic proteins (BMPs) (Zou et al., 1998) , or Tgfb (Serra et al., 1997) , Cbfa1 is not a negative but a positive regulator essential for normal differentiation. Cbfa1 may exert its effect through three possible mechanisms. First, Cbfa1 could regulate chondrocyte differentiation directly through the expression in hypertrophic and pre-hypertrophic chondrocytes. Second, hypertrophy is regulated indirectly through the expression of signaling molecules in perichondrial cells, and third, a combination of both mechanisms.
The molecular control mechanisms that govern the differentiation of chondrocytes from one stage to the next remain largely unknown. In vitro studies indicate that differentiation of chondrocytes from the resting state to hypertrophy is an intrinsic process that is not dependent on outside signaling (Böhme et al., 1995; Gibson et al., 1997) . However, signals from the perichondrium, the adjacent bone, and/or within the chondrocytes are likely to control the rate of differentiation to warrant a timely and coordinate rate of long bone growth. One regulative pathway involving two signaling molecules, Indian hedgehog (Ihh) and Parathyroid-related peptide (PTHrP), has recently been described. Ihh and PTHrP control, through a negative feedback loop involving patched (ptc) and the PTHrP-receptor, the differentiation of proliferating cells into hypertrophic cells Vortkamp et al., 1996) .
To investigate the role of the Ihh feedback loop in Cbfa1 −/− mice we performed in situ hybridization experiments with an Ihh specific probe. Again, different results were obtained for the individual forelimb segments. While the anlage of the humerus showed no expression of Ihh, moderate to strong expression was observed in the anlagen of the phalanges and radius/ulna. However, while expression in radius/ulna persisted until birth, no expression was demonstrable in the phalanges after E16.5. These results are in good agreement with those obtained for Col-X expression ( Table 1) .
The different results in the three fore limb segments indicate that Cbfa1 is involved in the initiation as well as in the maintenance of hypertrophy. Initiation is completely blocked in the humerus and delayed in radius/ulna, whereas hypertrophy is initiated in the phalanges, but not maintained. This concept is supported by the expression patterns of Ihh and Col-X. Cbfa1 could exert its effects through mediators expressed in the perichondrium. Expression in the perichondrium reaches beyond the zones of hypertrophy, transition and proliferation up to the resting zone (Fig.  2G,H) . It thus coincides with the differentiation process in the early anlage and precedes expression of Ihh. In this scenario, signals from the perichondrium that are controlled by Cbfa1 would initiate and control the differentiation process and expression in pre-hypertrophic and hypertrophic cells would control terminal differentiation. Recent findings have demonstrated that the perichondrium plays a major role in the regulation of chondrocyte differentiation. It has been suggested that Ihh signals to the perichondrium, which expresses ptc, a proposed Hedgehog target that is also involved in reception of the HH signal . Zou et al. (1998) provide evidence that Ihh, through its receptor in the perichondrium, regulates bmp expression, which in turn signals to the bmp-receptor Ia (bmpr-Ia). Ihh and bmpr-Ia appear to have similar effects on hypertrophy and are negative regulators of chondrocyte differentiation. This concept is supported by the recent finding of Long and Linsenmayer (1998) that removal of the perichondrium leads to an increase in proliferation and differentiation. In contrast, Cbfa1 is a positive regulator of differentiation. Thus, a significant role of Cbfa1 in perichondral cells in the regulation of chondrocyte differentiation is unlikely.
The overlapping expression patterns of Cbfa1 and Ihh within the growing cartilage anlage make a direct regulation of Ihh through Cbfa1 possible. However, considering the timely expression of Ihh in the phalangeal anlagen and the 
E17.5
The three genes were used as markers for chondrocyte differentiation. Note lack of expression of all three markers in humerus, delayed onset of expression in radius/ulna and loss of expression at E17.5 in phalanges. +, strong expression (similar to wt); (+), weak expression (significantly less than wt); −, no expression; n.e., not expressed in wt.
low level of expression in this area, this does not seem likely. Alternatively, Cbfa1 controls chondrocyte differentiation through a separate pathway that functions in parallel to the Ihh-PTHrP pathway. The expression of Cbfa1 in the perichondrium is likely to determine precursors along the osteoblast lineage as indicated by the lack of osteoblasts in Cbfa1 −/− mice. Has the expression of Cbfa1 in hypertrophic chondrocytes a similar function? The fate of terminally differentiated chondrocytes has been a matter of long standing debates. While it has been widely demonstrated that the majority of chondrocytes undergo apoptosis during their terminal stages of development, their expression of bone-specific proteins, such as osteopontin, bone sialoprotein, or alkaline phosphatase, give rise to the question whether all chondrocytes have the same developmental fates. It has been postulated that a subset of chondrocytes 'transdifferentiates' into osteoblasts (Kahn and Simmons, 1977; Thesing et al., 1991) , a process that requires the dedifferentiation of a chondrocyte to an early lineage stage followed by redifferentiation to an osteoblast. While such transdifferentiation has been only demonstrated in cultured chondrocytes, organ culture models using cut chicken growth plates have demonstrated asymmetric cell divisions in hypertrophic chondrocytes with diverging fates of the daughter cells, where one daughter cell died and the other remained viable with an osteoblast-like phenotype (Roach et al., 1995) . These and other studies demonstrate the potential of terminally differentiated cells for a change in lineage commitment from chondrocytes to osteoblasts. The expression of Cbfa1 in this subset of cells argues in favor for such a concept. 
Experimental procedures
Mice
Mice in which the Cbfa1 gene had been inactivated through the insertion of a neomycin/lacZ cassette and their wild type litter mates were used for all experiments. Genotyping was performed by extracting DNA from tails or extraembryonic membranes. A multiplex PCR was used to amplify a 600 bp fragment of exon 1 and/ or a 500 bp fragment of the neomycin/exon 1 sequence. The PCR conditions were: 4 min at 94°C, 34 cycles of 40 s at 55°C, followed by 72°C for 40 s, and 72°C for 10 min. Embryos between E10.5 and E17.5 were obtained from timed matings. Noon at the day of the vaginal plug was considered as day 0.5 post-coitus. Embryos between E10.5 and E17.5 were collected.
Histology and staining
Embryos from E13.5 to E17.5 and mice at ages 1 week and 3 months were collected for histological analysis. For each time point at least 5 embryos of the different genotypes (+/ + , +/ − , −/ − ) were used. The fore limbs were removed and fixed in 4% buffered formalin for 12 h. The samples were then either dehydrated and embedded in paraffin or processed for frozen sections. Great care was taken to obtain full length sections of the three skeletal segments of the upper limb, i.e. humerus, radius and phalanges. Eightmicrometer sections were cut and mounted on triethoxyethanolamine treated slides so that the sections of wt, heterozygous, and Cbfa1 −/− mice were on one slide. These sections were then processed for either standard H & E staining, van Kossa staining, or for in situ hybridization. For lacZ staining, embryos were fixed for 20 min at 4°C in fixing solution (0.2% glutaraldehyde, 5 mM EGTA pH 7.3, 2 mM MgCl 2 , 2% paraformaldehyde, in 0.1 M sodium phosphate pH 8.8), washed in 0.1 M sodium phosphate pH 8.0 containing 2 mM MgCl 2 , and subsequently stained with X-Gal at 37°C over night. Samples were then washed in PBS and stored in paraformaldehyde. For a precise localization of b-galactosidase activity at the cellular level whole embryos or parts of embryos were plastic embedded using the Historesin embedding kit (Leica, Germany). Blocks were cut at 3.5 mm thickness with a Reichert-Jung microtome, transferred onto clean glass slides, dried and mounted with a gelatine-based mounting media. Every 10th section was counter stained with hematoxilin. Slides were examined under dark-field illumination using an Olympus BX-60 microscope. Under dark-field illumination the microcrystalline indigo dye appears as isolated pink particles in the cytoplasm of positive cells (Lazik et al., 1996) .
In situ hybridization
Several stage-specific markers were used to characterize the differentiation process in wt, heterozygous and homozygous mice. Collagen type II is a marker for differentiated chondrocytes, whereas collagen type I is expressed in bone and perichondrium but not in cartilage. Collagen type X is an excellent marker for hypertrophy and osteopontin is expressed only is calcified hypertrophic cells. Ihh, a signaling protein from the hedgehog family that is involved in the regulation of chondrocyte differentiation is expressed in pre-hypertrophic chondrocytes of the transition zone.
In situ hybridization using digoxigenin labeled riboprobes was performed as described (Huang et al., 1997) . Probes were generated by PCR from genomic DNA or cDNA with the T7 promotor sequence added to the 3′ primer. PCR products were column purified (Qiagen, Germany) and the antisense riboprobe synthesized with T7 RNA polymerase and digoxigenin labeled according to the manufacturer's instructions (Boehringer Mannheim, Germany). The limbs of early stage embryos and Cbfa1 −/− embryos were cut in serial sections to assure access to the entire anlage. Sections of wt, Cbfa1 +/− , and Cbfa1 −/− embryos were processed on the same slide to assure the same treatment and to obtain a sufficient positive control.
Whole mount in situ hybridization was performed as described (Henrique et al., 1995) . To obtain Cbfa1 specific signals, a unique 500 bp sequence from the 3′ untranslated part of the Cbfa1 gene was amplified using the primers CCTTAAGCAGTTGGTACCGG and AGTACCTGCAG-CAAGTCTG with the T7 promotor sequence added to the 3′ primer. Digoxigenin labeled probes were produced as described above.
